| Literature DB >> 31071592 |
Tory R Spindle1, Marcel O Bonn-Miller2, Ryan Vandrey3.
Abstract
Laws regulating cannabis have changed radically in the U.S. and abroad. Historically, users smoked dried cannabis flowers that contained Δ9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis, as the principal product constituent. Coincident with cannabis legalization and increased interest in medicinal use of the plant, there is now an expansive retail cannabis marketplace with novel cannabis products, formulations, and methods of administration. In this review, we describe emergent cannabis product chemotypes (e.g. THC-dominant, CBD-dominant, balanced or 'hybrid' with high concentrations of THC and CBD), product formulations (e.g. edibles, concentrates), and methods of administration (e.g. smoked, vaporized, orally ingested). Psychologists can play a pivotal role in studying the health impact of cannabis legalization and conducting research to inform product regulation.Entities:
Mesh：
Substances：
Year: 2019 PMID： 31071592 PMCID： PMC7041884 DOI： 10.1016/j.copsyc.2019.04.002
Source DB: PubMed Journal: Curr Opin Psychol ISSN： 2352-250X